MEDANTA.NS Cash Flow
Global Health Ltd.
Profit & Loss Balance Sheet Cash Flow
Cash Flow · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 22:31
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Net Cash from Operating Activities | ₹644.52 Cr. | ₹612.09 Cr. | ₹623.76 Cr. | ₹714.39 Cr. | CashFlowsFromUsedInOperatingActivities |
| Net Cash from Investing Activities | ₹-342.34 Cr. | ₹-440.80 Cr. | ₹-720.94 Cr. | ₹-1,065.11 Cr. | CashFlowsFromUsedInInvestingActivities |
| Net Cash from Financing Activities | ₹345.64 Cr. | ₹-513.92 Cr. | ₹-97.23 Cr. | ₹247.85 Cr. | CashFlowsFromUsedInFinancingActivities |
| Effect of Exchange Rate Changes | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | EffectOfExchangeRateChangesOnCashAndCashEquivalents |
| Net Increase/(Decrease) in Cash | ₹647.81 Cr. | ₹-342.63 Cr. | ₹-194.41 Cr. | ₹-102.87 Cr. | IncreaseDecreaseInCashAndCashEquivalents |
| Cash and Cash Equivalents (Closing) | ₹119.43 Cr. | ₹767.24 Cr. | N/A | N/A | CashAndCashEquivalentsCashFlowStatement |
Every figure above is the exact value of the named XBRL element from MEDANTA.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).